Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Cardiothorac Surg ; 32(3): 481-7, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17643993

ABSTRACT

OBJECTIVE: Perioperative myocardial ischemia is less pronounced in off-pump coronary artery bypass (OPCAB) compared to on-pump coronary artery bypass; however, the threshold over which the postoperative release of cardiac troponin I (cTnI) release and creatine kinase-MB (CK-MB) after OPCAB should be considered clinically relevant is unknown. The study was designated to evaluate if perioperative myocardial damage, measured by means of postoperative release of cTnI and CK-MB, has an influence on short- and mid-term outcome after OPCAB operations. METHODS: Two hundred and sixty-one unselected patients undergoing OPCAB had cTnI and CK-MB measured preoperatively and nine times postoperatively. Postoperative peak values were evaluated and the 80th percentiles were used to segregate the population into two groups for each marker. The following cut-offs were used: 7.1 ng/dl for cTnI peak and 36.3 ng/dl for CK-MB peak. RESULTS: Patients with cTnI>7.1 ng/ml (n=51) and CK-MB>36.3 ng/ml (n=48) had a longer mechanical ventilation and ICU length of stay. Nevertheless, hospital mortality did not differ between groups. Survival after 3 years was 92.8+/-2.3% and 81.8+/-6.2 for patients with postoperative cTnI peak7.1 ng/ml, respectively (p=0.003). It was 93+/-2.2% and 80+/-6.8% for patients with CK-MB36.3 ng/ml, respectively (p=0.005). Adjusted hazard ratios for mid-term mortality were HR 2.7 (CI 1-7.6), p=0.05 for cTnI>7.1 ng/dl and HR 3.1 (CI 1-9.1), p=0.04 for CK-MB>36.3 ng/ml. CONCLUSION: Perioperative myocardial damage should not be considered an innocuous event following OPCAB operations since the survival rate over 3 years is significantly worse in patients with the highest postoperative peak release of cTnI and CK-MB.


Subject(s)
Coronary Artery Bypass, Off-Pump/adverse effects , Creatine Kinase, MB Form/blood , Myocardial Ischemia/etiology , Postoperative Complications/etiology , Troponin I/blood , Aged , Aged, 80 and over , Biomarkers/blood , Coronary Artery Bypass, Off-Pump/mortality , Female , Hospital Mortality , Humans , Male , Myocardial Ischemia/blood , Postoperative Complications/mortality , Retrospective Studies , Risk Assessment , Risk Factors , Survival Analysis
2.
Obes Surg ; 15(5): 716-8, 2005 May.
Article in English | MEDLINE | ID: mdl-15946468

ABSTRACT

A morbidly obese patient is reported who underwent insertion of a BioEnterics Intragastric Balloon (BIB) as a pre-surgical procedure (ie. prior to restrictive gastric banding). While carrying the BIB, the patient suffered an episode of severe supraventricular tachyarrhythmia (atrial fibrillation). Although such an event is not definitely correlated to the BIB, the episode led us to modify the pre-treatment protocol, introducing dynamic Holter ECG into the work-up investigations and excluding subjects with a pathological cardiac rhythm.


Subject(s)
Atrial Fibrillation/etiology , Gastric Balloon/adverse effects , Obesity, Morbid/surgery , Tachycardia/etiology , Adult , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...